Synthetic ‘kill switch’ could fast track new immunotherapies, turning bacterial armies against cancer tumours, study shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results